CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary SharesNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$8.47M
P/E Ratio
—
EPS
$-0.11
Beta
—
52W High
$9.50
52W Low
$0.28
50-Day MA
$0.39
200-Day MA
$2.03
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
Fundamentals
| Revenue (TTM) | 30,330 |
| Gross Profit (TTM) | -21,002 |
| EBITDA | $-2.81M |
| Operating Margin | -8643.00% |
| Return on Equity | -139.10% |
| Return on Assets | -28.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.28 |
| Price-to-Book | 1.16 |
| Price-to-Sales (TTM) | 279.13 |
| EV/Revenue | 165.07 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -43.90% |
| Shares Outstanding | $7.37M |
| Float | $7.37M |
| % Insiders | 0.00% |
| % Institutions | 0.66% |
Data last updated: 4/7/2026